Albuterol and Seborrhoeic dermatitis - a phase IV clinical study of FDA data

Summary:

Seborrhoeic dermatitis is reported as a side effect among people who take Albuterol (albuterol), especially for people who are male, 60+ old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Seborrhoeic dermatitis when taking Albuterol. It is created by eHealthMe based on reports of 159,093 people who have side effects when taking Albuterol from the FDA, and is updated regularly.

What is Albuterol?

Albuterol has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 161,053 Albuterol users. Check the latest studies of Albuterol.

What is Seborrhoeic dermatitis?

Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp) is found to be associated with 361 drugs and 513 conditions by eHealthMe. Check the latest studies of Seborrhoeic dermatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

159,093 people reported to have side effects when taking Albuterol.
Among them, 59 people (0.04%) have Seborrhoeic dermatitis.

Could Albuterol cause Seborrhoeic dermatitis?

Among these 59 people:

What is the gender of people who have Seborrhoeic dermatitis when taking Albuterol? *

female: 22.03 %
male: 77.97 %

What is the age of people who have Seborrhoeic dermatitis when taking Albuterol? *

What are other drugs people take besides Albuterol? *

What are other side effects people have besides Seborrhoeic dermatitis? *

Dyspnea (difficult or laboured breathing): 39 people, 66.10%
Depression: 37 people, 62.71%
Fatigue (feeling of tiredness): 36 people, 61.02%
Joint Pain: 35 people, 59.32%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 35 people, 59.32%
Cough: 34 people, 57.63%
Exostosis (formation of new bone on the surface of a bone): 33 people, 55.93%
Chest Pain: 31 people, 52.54%
Multiple Myeloma (cancer of the plasma cells): 29 people, 49.15%
Pain: 29 people, 49.15%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 25 people, 42.37%
High Blood Pressure: 19 people, 32.20%
Mood Swings (an extreme or rapid change in mood): 18 people, 30.51%
Fluid Retention (an abnormal accumulation of fluid in the blood): 18 people, 30.51%
High Blood Cholesterol: 18 people, 30.51%
Diarrhea: 18 people, 30.51%
Joint Pain: 18 people, 30.51%
Seasonal Allergy (allergic condition due to certain season): 13 people, 22.03%
Blood Triglycerides Decreased: 13 people, 22.03%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 10 people, 16.95%

* Approximation only. Some reports may have incomplete information.

Do you take Albuterol and have Seborrhoeic dermatitis?

- Check whether Seborrhoeic dermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Albuterol:

Albuterol (161,053 reports)

Browse all side effects of Albuterol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (361 drugs)

Browse all the conditions that are associated with Seborrhoeic dermatitis:

Seborrhoeic dermatitis (513 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol (the active ingredients of Albuterol) and Albuterol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.